Trace Elements, Heavy Metals and Other Biochemical Parameters in Malignant Glioma Patients

dc.contributor.author Arslan, Mehmet
dc.contributor.author Demir, Halit
dc.contributor.author Arslan, Harun
dc.contributor.author Gokalp, A. Samet
dc.contributor.author Demir, Canan
dc.date.accessioned 2025-05-10T17:48:36Z
dc.date.available 2025-05-10T17:48:36Z
dc.date.issued 2011
dc.description Demir, Canan/0000-0002-4204-9756; , Abdulsemat Gokalp/0009-0009-2061-6412 en_US
dc.description.abstract Aim: We aimed to assess relevance of mineral, trace element and heavy metal levels in patients with malignant gliomas. Methods: In this study, erythrocyte catalase (CAT), and carbonic anhydrase (CA), serum copper (Cu.), zinc (Zn), lead (Pb), iron (Fe), cadmium (Cd), cobalt (Co), manganese (Mn), and magnesium (Mg) levels were measured in 22 healthy humans and 22 malignant glioma patients. Metal concentrations were assessed by atomic adsorption spectrophotometry, while biochemical methods were used for CAT and CA. Results: The Cd, Fe, Mg, Mn, Pb and Zn levels were significantly elevated in the patients as a whole compared to controls(P<0.05), while Cu was decreased and Co demonstrated no change. Although mean CAT activity were significantly lowered, CA exhibited significant increase. Conclusions: The results of the current study indicate that antioxidant enzymes may have a role in the genesis of considerable oxidative stress in patients with malignant glioma. CAT and CA seem to play particular roles in the pathophysiology of this disease. en_US
dc.identifier.issn 1513-7368
dc.identifier.scopus 2-s2.0-79958782515
dc.identifier.uri https://hdl.handle.net/20.500.14720/17168
dc.language.iso en en_US
dc.publisher Asian Pacific Organization Cancer Prevention en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Malignant Glioma en_US
dc.subject Catalase en_US
dc.subject Carbonic Anhydrase en_US
dc.subject Trace Elements en_US
dc.subject Heavy Metals en_US
dc.title Trace Elements, Heavy Metals and Other Biochemical Parameters in Malignant Glioma Patients en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Demir, Canan/0000-0002-4204-9756
gdc.author.id , Abdulsemat Gokalp/0009-0009-2061-6412
gdc.author.scopusid 57158783300
gdc.author.scopusid 56259656000
gdc.author.scopusid 21333559300
gdc.author.scopusid 49461235300
gdc.author.scopusid 57197170055
gdc.author.wosid Demir, Canan/Gwm-8855-2022
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Demir, Halit] Yuzuncu Yil Univ, Dept Chem, Div Biochem, Fac Sci, Van, Turkey; [Arslan, Mehmet; Gokalp, A. Samet] Yuzuncu Yil Univ, Dept Neurosurg, Fac Med, Van, Turkey; [Arslan, Harun] Yuzuncu Yil Univ, Dept Radiol, Van Training & Res Hosp, Van, Turkey; [Demir, Canan] Yuzuncu Yil Univ, Dept Biostat, Fac Med, Van, Turkey en_US
gdc.description.endpage 451 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 447 en_US
gdc.description.volume 12 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality N/A
gdc.identifier.pmid 21545211
gdc.identifier.wos WOS:000293172800021
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files